AISkin

What AISkin does

AISkin (Aiskin.cn / 罕见病关爱平台) is a Chinese-language rare disease information and patient-care platform operating as a self-serve web property at aiskin.cn. Founded in 2017 and based in Fengxian, China, the platform catalogs 254 rare diseases across 16 specialty categories — including chromosomal abnormalities, congenital metabolic disorders, neurological, dermatological, endocrine, musculoskeletal, immune, and hematologic diseases — through a structured encyclopedia in which each disease entry contains prevalence, inheritance pattern, onset age, typical and warning symptoms, diagnosis, treatment, FAQ, and references to the National Health Commission's Rare Disease Diagnosis and Treatment Guidelines. Adjacent modules include a curated resource directory linking to 23 charity organizations, 27 medical institutions, 8 government agencies, 10 patient communities, and 13 information resources; a news and public-health editorial feed; patient self-registration; a six-track volunteer recruitment portal; and a donation service. The platform is governed by PRC law, explicitly disclaims any commercial or trademark affiliation, and positions itself as an independent public welfare/educational resource serving rare disease patients, families, healthcare professionals, and the broader Chinese public.

The technology stack is a standard Chinese-language CMS-based web platform with email/password user accounts, structured disease-detail templates, category-page hierarchy, and a single third-party payment integration — Yeepay-hosted donation processing at donate.yeepay.com with UTM attribution back to the platform. No proprietary algorithms, no public API or SDK, no mobile applications, and no AI/ML capabilities are disclosed. GTM is community-led and content-driven: organic SEO on Chinese-language disease pages, Weibo Rare Disease Super Topic and Douban Rare Disease Group communities, RareConnect international community linking, and promotion of the Rare Disease Cooperation Exchange Conference (rdforum.chinaicf.org). Distribution is single-country domestic via self-serve web and direct email at [email protected].

The revenue model is exclusively voluntary charitable donations processed through Yeepay, which are irrevocable except by law and used solely for designated charitable purposes with periodic public disclosure of fund usage. There are no subscription tiers, no advertising, no B2B contracts, no marketplace fees, and no data-licensing revenue. The core operating team is described as four named professionals (a medical advisor, a nursing advisor, a social worker, and a volunteer coordinator) supplemented by a volunteer-driven extended workforce, which is consistent with a small public-welfare operation rather than a commercial venture. The About Us page reports 254 catalogued diseases, 17,121 cumulative donation units, and counters for 28 patient organizations and 15 partner resources, but no revenue figure, funding history, or ownership structure is disclosed.

Name

AISkin

Legal name

Aiskin

Website

https://aiskin.cn

Company type

Private

Founded year

2017

Operating status

Operating

Headcount range

51–100 employees

Short description

AISkin (Aiskin.cn) operates a Chinese-language rare-disease information platform that catalogs 254 diseases in a structured encyclopedia and connects patients, families, healthcare professionals, and donors with medical institutions, patient communities, and charitable resources via voluntary donations processed through Yeepay.

Ownership category

akta.pro rank

Product category

Rare Disease Information and Patient Support

NAICS

Medical and Diagnostic Laboratories (62151), All Other Professional, Scientific, and Technical Services (54199)

SIC

Services-Misc Health & Allied Services, Nec (8090), Services-Health Services (8000)

akta.pro primary industry

Disease Registries (Cancer, Immunization, Rare Disease, etc.) (HLAJAJAE)

akta.pro secondary industry

Rare Disease & Special Needs Support Organizations (BPAGACAM)

Keywords

• Rare disease information
• Patient support platform
• Health encyclopedia
• Public health news
• Charitable donation platform

Headquarters

HQ city

Fengxian

HQ country

China

HQ region

Asia

Offices1 record

Markets served

GTM type

B2C

Offering type

Services

Cost components

Personnel, Technology or R&D, Operations, Marketing or Sales, Others

Revenue model

1. Charitable Donations: Voluntary charitable donations from the public, processed through yeepay.com payment platform. Per terms of use, donations are irrevocable (except by law), used solely for designated charitable purposes, with periodic public disclosure of fund usage.

Pricing tiers

Go-to-market motion2 records

Distribution channels3 records

Marketing channels7 records

Core offering

AISkin operates aiskin.cn, a Chinese-language rare-disease information and patient-care platform built around a structured encyclopedia of 254 rare diseases (each with prevalence, inheritance, symptoms, diagnosis, treatment, FAQ and references). It also publishes rare-disease and public-health news, supports patient self-registration, recruits volunteers across six functional tracks, maintains a curated directory of rare-disease charities, medical institutions, government agencies and patient communities, and accepts voluntary charitable donations processed through Yeepay.

Product overview

AISkin is a single-platform rare-disease care portal (aiskin.cn) that pairs a deeply structured Rare Disease Encyclopedia (covering 254 diseases across 16 specialty categories, each with prevalence, inheritance, symptoms, diagnosis, treatment, FAQ, and references) with adjacent community and support modules — News & Public Health Information, Patient Registration, Volunteer Recruitment, a curated Rare Disease Resource Directory, a Yeepay-backed Donation Service, and a user-account system for login/registration and patient story submission. The encyclopedia is the core asset and drives navigation, while the directory, news feed, donation, and volunteer flows serve as engagement and outreach modules around it. The platform explicitly states it has no affiliation with any company or trademark and is purely educational.

Differentiator

Problem solved

Functional benefit

Products and services

• Rare Disease Encyclopedia (罕见病百科) A browsable, category-organized encyclopedia covering 254 rare diseases, each with a dedicated detail page describing prevalence, inheritance pattern, onset age, symptoms, diagnosis, treatment, FAQ and references; designed for patients, families and the general public seeking authoritative rare-disease information in Chinese.
• News & Public Health Information Hub (新闻资讯) An article-publishing hub for rare-disease-related news, drug approvals, funding announcements and public-health outbreak coverage, with per-article view counts, dates and category filtering including a public-health subcategory; aimed at patients, families, healthcare professionals and the general public.
• Patient Registration (患者登记) A self-service registration entry point that lets rare-disease patients or their families enrol in the platform's database, supporting the platform's mission to connect patients, families and society.
• Donation Service (我要捐助) A donation funnel that hands off to Yeepay's hosted payment page for processing charitable contributions, with UTM-based attribution back to the platform; donations are irrevocable except by law, used solely for designated charitable purposes and subject to periodic public disclosure of fund usage.
• Volunteer Recruitment Portal (志愿者招募) Volunteer sign-up flow with six tracks (emotional support, content editing, activity organization, technical maintenance, community service, translation), capturing contact phone, weekly availability, area of interest and motivation; applicants must be at least 18 years old.
• Rare Disease Resource Directory (罕见病导航) A curated directory of authoritative rare-disease resources grouped into five buckets: public-welfare organizations (23), medical institutions (27), government agencies (8), patient communities (10) and information resources (13), linking to Chinese and international rare-disease bodies such as CORD, Orphanet, EURORDIS, NORD and NIH/NCATS.

Quantifiable outcome

• Catalogs 254 rare diseases across 17+ disease categories
• +1 more outcomes

Segments4 records

Ideal customer profiles4 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Integration1 record

Feature5 records

Partnerships

18 partnerships are on record, tiered core and minor.

• 中国罕见病发展中心 (China Alliance for Rare Diseases, CORD)coreStrategic or Co-development PartnerFeatured as a core resource link in the platform's 罕见病导航 (Rare Disease Navigation) directory under 公益组织 (charity organizations). CORD is listed alongside other leading Chinese rare disease support organizations as part of Aiskin's curated resource ecosystem.
• 瓷娃娃罕见病关爱中心 (China-Dolls Center for Rare Disorders)coreStrategic or Co-development PartnerFeatured resource link under 公益组织 (charity organizations) for osteogenesis imperfecta and other rare disease support. Listed in Aiskin's curated rare disease resource directory.
• 蔻德罕见病中心 (Chinese Organization for Rare Disorders)coreStrategic or Co-development PartnerListed in Aiskin's resource directory as a comprehensive rare disease service platform in China.
• Orphanet (European rare disease information portal)coreStrategic or Co-development PartnerFeatured as a key international information resource link on the Aiskin platform, providing authoritative European rare disease data.
• EURORDIS (European Organisation for Rare Diseases)minorStrategic or Co-development PartnerListed as an international rare disease organization resource link on the Aiskin platform.
• Rare Diseases InternationalminorStrategic or Co-development PartnerListed as a global rare disease patient organization alliance resource link.
• 中国红十字基金会 (China Red Cross Foundation)coreStrategic or Co-development PartnerFeatured as a major humanitarian assistance and health service resource under the public welfare organizations section.
• 中国初级卫生保健基金会 (China Primary Health Care Foundation)minorStrategic or Co-development PartnerListed as a public health charity resource for Aiskin's users.
• 中国妇女发展基金会 (China Women's Development Foundation)minorStrategic or Co-development PartnerListed as a women's health public welfare project resource.
• 中国残疾人福利基金会 (China Foundation for Disabled Persons)minorStrategic or Co-development PartnerListed as a disability rights protection resource.
• 国家卫生健康委员会 (National Health Commission of China)coreStrategic or Co-development PartnerListed as the authoritative Chinese government health authority in Aiskin's resource directory; the platform cites the National Health Commission's Rare Disease Diagnosis and Treatment Guidelines as a primary reference for encyclopedia content.
• 国家医疗保障局 (National Healthcare Security Administration of China)minorStrategic or Co-development PartnerListed as a government resource link for healthcare security matters relevant to rare disease patients.
• 北京协和医院罕见病中心 (Peking Union Medical College Hospital Rare Disease Center)coreImplementation/ SI/ Consulting PartnerFeatured as the National Rare Disease Diagnosis and Treatment Center in Aiskin's resource directory under medical institutions.
• Mayo ClinicminorStrategic or Co-development PartnerListed as an international medical institution resource link on the platform.
• 罕见病合作交流会 (Rare Disease Cooperation Exchange Conference)coreStrategic or Co-development PartnerPromoted as a cooperation exchange platform for the rare disease community (rdforum.chinaicf.org); Aiskin encourages community participation in this forum and lists it under public welfare recruitment.
• IlluminaminorStrategic or Co-development PartnerListed as a leading gene sequencing technology company in the resource directory under information resources.
• BioMarin PharmaceuticalminorStrategic or Co-development PartnerListed as a rare disease drug R&D enterprise in the resource directory under information resources.
• National Organization for Rare Disorders (NORD)minorStrategic or Co-development PartnerReferenced as a rare disease patient rights advocacy organization in Aiskin's resource directory.

Scale indicators5 records

Recent moves5 records

Expansion highlights5 records

Direct peers

• Orphanet: European rare disease information portal with a deeply curated rare disease encyclopedia and patient resources. It is the international benchmark for the kind of structured disease content that AISkin's 254-disease encyclopedia is built to emulate in Chinese.
• National Organization for Rare Disorders (NORD): US-based rare disease patient advocacy organization that curates disease information, patient stories, and resource directories. NORD is already linked on AISkin's resource directory and serves a comparable patient-and-family awareness role in the US.
• EURORDIS - Rare Diseases Europe: European alliance of rare disease patient organizations that aggregates patient communities, advocacy, and disease information. It is linked on AISkin's resource directory and represents a comparable federated patient-community model.
• China Alliance for Rare Diseases (CORD): Leading Chinese rare disease service platform and patient advocacy organization. CORD is featured as a core resource partner on AISkin's directory and operates a directly overlapping mission in China around rare disease awareness and patient support.
• China-Dolls Center for Rare Disorders: Chinese rare disease support organization focused on osteogenesis imperfecta and other rare conditions. Listed as a core resource partner on AISkin's directory; comparable patient-advocacy model within the Chinese rare disease ecosystem.
• EveryLife Foundation for Rare Diseases: US rare disease patient rights advocacy organization. Linked on AISkin's resource directory and represents a comparable advocacy-and-awareness peer operating a public-facing educational platform.
• Rare Diseases International: Global alliance of rare disease patient organizations. Listed on AISkin's resource directory and provides a comparable umbrella-level rare disease advocacy and awareness function at international scale.

Broad incumbents

• NIH National Center for Advancing Translational Sciences (NCATS): US government rare disease research and translation hub. Listed on AISkin's resource directory; comparable as a broader institutional operator of rare disease information and research resources rather than a peer-size direct competitor.
• Peking Union Medical College Hospital Rare Disease Center: Designated national rare disease diagnosis and treatment center in China. Featured as a core medical-institution resource on AISkin's directory; overlaps in serving rare disease patients but from a clinical-care perspective rather than as an information platform.

Others

• Illumina: Global gene sequencing technology leader listed on AISkin's resource directory under information resources. Comparable as an adjacent enabling player in the rare disease ecosystem through genetic diagnostics, not a direct content or patient-platform competitor.

Market position

Strengths4 records

Weaknesses5 records

Competitive moat6 records

Key risks7 records

Key highlights6 records

Customer concentration

Compliance2 records

Revenue estimate

Valuation estimate

Number of profiles

Profiles5 records

Funding overview

Funding rounds1 record

Investors1 record

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about AISkin